Literature DB >> 19106169

Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis.

M Kawai, K Hagihara, T Hirano, Y Shima, Y Kuwahara, J Arimitsu, M Narazaki, A Ogata, I Kawase, T Kishimoto, T Tanaka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19106169     DOI： 10.1093/rheumatology/ken468

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  15 in total

Review 1.  Relapsing polychondritis: a review.

Authors:  Aman Sharma; Karthik Gnanapandithan; Kusum Sharma; Susmita Sharma
Journal:  Clin Rheumatol       Date:  2013-07-26       Impact factor: 2.980

2.  Fever of unknown origin in a patient with red ears: relapsing polychondritis.

Authors:  Juliana Nunes Avila; Susana Bonacho Carvalho; Graça Tavares; Ruben Garcia
Journal:  BMJ Case Rep       Date:  2014-02-07

Review 3.  A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

Authors:  Andrea Rubbert-Roth; Daniel E Furst; Jan Michael Nebesky; Angela Jin; Erhan Berber
Journal:  Rheumatol Ther       Date:  2018-03-03

Review 4.  Efficacy of tocilizumab for psychiatric symptoms associated with relapsing polychondritis: the first case report and review of the literature.

Authors:  Lijun Liu; Shengyun Liu; Wenjuan Guan; Lei Zhang
Journal:  Rheumatol Int       Date:  2016-06-03       Impact factor: 2.631

Review 5.  [Interleukin-6 inhibition as a potential therapeutic target in rheumatic diseases].

Authors:  C Iking-Konert; P Bartz-Bazzanella; D Falagan; M W Hofman; A Schwarting; T Dörner
Journal:  Z Rheumatol       Date:  2014-04       Impact factor: 1.372

Review 6.  Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis.

Authors:  Ghassan Elourimi; Michael Soussan; Ursula Warzocha; Hélène Bugaud; Robin Dhôte; Sébastien Abad
Journal:  Rheumatol Int       Date:  2017-09-30       Impact factor: 2.631

7.  Sustained response to tocilizumab in a patient with relapsing polychondritis with aortic involvement: a case based review.

Authors:  Rebecca Stael; Vanessa Smith; Ruth Wittoek; David Creytens; Herman Mielants
Journal:  Clin Rheumatol       Date:  2014-05-16       Impact factor: 2.980

Review 8.  Inhibition of the interleukin-6 signaling pathway: a strategy to induce immune tolerance.

Authors:  Cheng Zhang; Xi Zhang; Xing-Hua Chen
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

9.  Meningoencephalitis in relapsing polychondritis: A case report.

Authors:  Haruki Matsumoto; Ryo Tokimura; Yuya Fujita; Naoki Matsuoka; Tomoyuki Asano; Shuzo Sato; Jumpei Temmoku; Makiko Yashiro-Furuya; Kenji Yoshida; Ryoma Takahashi; Shoko Tanaka; Yuya Itagaki; Mari Honma; Nozomu Matsuda; Hiroshi Watanabe; Kiyoshi Migita; Kazuaki Kanai
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

Review 10.  Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.

Authors:  Toshio Tanaka; Tadamitsu Kishimoto
Journal:  Int J Biol Sci       Date:  2012-10-24       Impact factor: 6.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.